Skinvisible Pharmaceuticals, Inc.

Skinvisible Pharmaceuticals, Inc. develops innovative polymer delivery vehicles and related compositions which when topically applied hold active ingredients on the skin for up to four hours and longer, thereby affording the active ingredient an extended timeframe to perform its intended function.

Aligned with its research and development focus, Skinvisible's primary objective is to license its patented technology Invisicare and sell its trademarked polymer delivery vehicles to established brand manufacturers and marketers of prescription and over-the-counter ("OTC") products in the dermatological, medical, cosmetic, and skincare markets. An added benefit for companies utilizing Invisicare is the opportunity to extend their existing product patent life.

For more corporate information, visit   www.skinvisible.com

Top